Cited by 405Pancreatic and Hepatic Oncology ResearchPancreatitis Pathology and TreatmentCytokine Signaling Pathways and Interactions

The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.

Oncogenic Kras Activates a Hematopoietic-to-Epithelial IL-17 Signaling Axis in Preinvasive Pancreatic Neoplasia

Open access

McAllister, Florencia, Bailey, Jennifer M., Alsina, Janivette, Nirschl, Christopher J., Sharma, Rajni, Fan, Hongni, Rattigan, Yanique, Roeser, Jeffrey C., Lankapalli, Rachana H., Zhang, Hao, Jaffee, Elizabeth M., Drake, Charles G., Housseau, Franck, Maitra, Anirban, Kolls, Jay K., Sears, Cynthia L., Pardoll, Drew M., Leach, Steven D.·2014·Cancer Cell

DOI 10.1016/j.ccr.2014.03.014PMC PMC4072043

Open this paper in CoChat — free account Open PDF

Abstract

Many human cancers are dramatically accelerated by chronic inflammation. However, the specific cellular and molecular elements mediating this effect remain largely unknown. Using a murine model of pancreatic intraepithelial neoplasia (PanIN), we found that Kras(G12D) induces expression of functional IL-17 receptors on PanIN epithelial cells and also stimulates infiltration of the pancreatic stroma by IL-17-producing immune cells. Both effects are augmented by associated chronic pancreatitis, resulting in functional in vivo changes in PanIN epithelial gene expression. Forced IL-17 overexpression dramatically accelerates PanIN initiation and progression, while inhibition of IL-17 signaling using genetic or pharmacologic techniques effectively prevents PanIN formation. Together, these studies suggest that a hematopoietic-to-epithelial IL-17 signaling axis is a potent and requisite driver of PanIN formation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.ccr.2014.03.014

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
A global double-fluorescent Cre reporter mouse
Muzumdar, M. D., Tasic, B., Miyamichi, K., Li, L., & Luo, L. (2007) · genesis · doi:10.1002/dvg.20335 · Cited by 3,491
Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer
Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma
Provenzano, P. P., Cuevas, C., Chang, A. E., Goel, V. K., Von Hoff, D. D., & Hingorani, S. R. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.01.007 · Cited by 2,195
EMT and Dissemination Precede Pancreatic Tumor Formation
Rhim, A. D., Mirek, E. T., Aiello, N. M., Maitra, A., Bailey, J. M., McAllister, F., Reichert, M., Beatty, G. L., Rustgi, A. K., Vonderheide, R. H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.025 · Cited by 2,136
Self-citation
A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses
Wu, S., Rhee, K.-J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H.-R., Huso, D. L., Brancati, F. L., Wick, E., McAllister, F., et al. (2009) · Nature Medicine · doi:10.1038/nm.2015 · Cited by 1,812
Self-citation
Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice
Guerra, C., Schuhmacher, A. J., Cañamero, M., Grippo, P. J., Verdaguer, L., Pérez-Gallego, L., Dubus, P., Sandgren, E. P., & Barbacid, M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.01.012 · Cited by 1,224
Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer
Jacobetz, M. A., Chan, D. S., Neesse, A., Bapiro, T. E., Cook, N., Frese, K. K., Feig, C., Nakagawa, T., Caldwell, M. E., Zecchini, H. I., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-302529 · Cited by 1,120
Dynamics of the immune reaction to pancreatic cancer from inception to invasion
Clark, C. E., Hingorani, S. R., Mick, R., Combs, C., Tuveson, D. A., & Vonderheide, R. H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0175 · Cited by 990

Flagged first, then by citations

Show all 63 references

Sorted by citations

Items 301–400 of 404

Hear Pancreatic Cancer Stem Cells ROR
Yao, W., & Maitra, A. (2019) · Cell · doi:10.1016/j.cell.2019.04.002 · Cited by 7
Self-citation
Distinct small molecule inhibitors of Kras specifically prime CTLA4 blockade therapy to transcriptionally reprogram Tregs and overcome resistance to suppress pancreas cancerPreprint
Mahadevan, K. K., Maldonado, A. S., Li, B., Bickert, A. A., Perdyan, A., Kumbhar, S. V., Piya, S., Sockwell, A. M., Morse, S. J., Arian, K. A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.28.640711 · Cited by 7
Self-citation
Streptococcus gallolyticus supernatant induces M2 macrophage polarization and activates IL-17 F signaling in colorectal tumorigenesis
Wang, J., Zhang, Y., Luo, D., Xu, J., Nie, X., Huang, C., Zhao, H., Zhu, M., Guo, X., Zhang, Y., et al. (2025) · Gut Pathogens · doi:10.1186/s13099-025-00731-2 · Cited by 6
Contextualizing TH17 cells in cancer
Pang, D., Bertocchi, A., Powrie, F. M., & Pohin, M. (2026) · Nature reviews. Immunology · doi:10.1038/s41577-025-01250-6 · Cited by 7
The hallmarks of pancreatic cancer
Kane, L. E., Hackett, D., Lyons, R. G., Ryan, B. M., & Maher, S. G. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218437 · Cited by 8
The Poorly Immunogenic Tumor Microenvironment of Pancreatic Cancer: The Impact of Radiation Therapy, and Strategies Targeting Resistance
Hughes, R., Snook, A. E., & Mueller, A. C. (2022) · Immunotherapy · doi:10.2217/imt-2022-0046 · Cited by 6
Bioinformatics analyses of infiltrating immune cell participation on pancreatic ductal adenocarcinoma progression and in vivo experiment of the therapeutic effect of Shuangshen granules
Hu, J., Jiang, J., Xu, B., Li, Y., Wang, B., He, S., Ren, X., Shi, B., Zhang, X., Zheng, H., et al. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117590 · Cited by 6
Jawbone Cavitation Expressed RANTES/CCL5: Case Studies Linking Silent Inflammation in the Jawbone with Epistemology of Breast Cancer
Lechner, J., Schulz, T., Lejeune, B., & von Baehr, V. (2021) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s295488 · Cited by 6
Molecular signaling in pancreatic ductal metaplasia: emerging biomarkers for detection and intervention of early pancreatic cancer
Li, X., He, J., & Xie, K. (2022) · Cellular Oncology · doi:10.1007/s13402-022-00664-x · Cited by 6
Involvement of the Gut Microbiome in the Local and Systemic Immune Response to Pancreatic Ductal Adenocarcinoma
Halle-Smith, J. M., Pearce, H., Nicol, S. M., Hall, L. A., Powell-Brett, S. F., Beggs, A. D., Iqbal, T. H., Moss, P. A. H., & Roberts, K. J. (2024) · Cancers · doi:10.3390/cancers16050996 · Cited by 6
Differential Diagnosis of Autoimmune Pancreatitis From Pancreatic Cancer by Analysis of Serum Gelatinase Levels
Felix, K., Dobiasch, S., Gaida, M. M., Schneider, K., Werner, J., Martens, E., Vandooren, J., & Opdenakker, G. (2015) · Pancreas · doi:10.1097/mpa.0000000000000576 · Cited by 6
IL17A Depletion Affects the Metabolism of Macrophages Treated with Gemcitabine
Roux, C., Mucciolo, G., Kopecka, J., Novelli, F., Riganti, C., & Cappello, P. (2021) · Antioxidants · doi:10.3390/antiox10030422 · Cited by 6
Inducible, but not constitutive, pancreatic REG/Reg isoforms are regulated by intestinal microbiota and pancreatic diseases
Zhou, Y., Komnick, M. R., Sepulveda, F., Liu, G., Nieves-Ortiz, E., Meador, K., Ndatabaye, O., Fatkhullina, A. R., Bozicevich, A. J., Juengel, B., et al. (2025) · Mucosal Immunology · doi:10.1016/j.mucimm.2025.05.003 · Cited by 5
Act1 drives chemoresistance via regulation of antioxidant RNA metabolism and redox homeostasis
Hong, L., Herjan, T., Chen, X., Zagore, L. L., Bulek, K., Wang, H., Yang, C. J., Licatalosi, D. D., Li, X., & Li, X. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20231442 · Cited by 5
Interleukin-17 promotes ovarian carcinoma SKOV3 cells via MTA1-induced epithelial-to-mesenchymal transition
(2020) · European Journal of Gynaecological Oncology · doi:10.31083/j.ejgo.2020.01.4933 · Cited by 5
Current Clinical Landscape of Immunotherapeutic Approaches in Pancreatic Cancer Treatment
Farhangnia, P., Ghomi, S. M., Mollazadehghomi, S., & Delbandi, A. (2023) · Interdisciplinary cancer research · doi:10.1007/16833_2023_163 · Cited by 5
Tryptophan intake and pancreatic cancer: findings from a case-control study
Luu, H. N., Pham, Y. T., Yuan, J., Brand, R. E., Pham, T. V., Dao, H. V., Le, C. T.-K., Huynh, N. Y. N., Nguyen, H. M., & Le, N. T. (2024) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000864 · Cited by 5
Aryl Hydrocarbon Receptor Knockout Accelerates PanIN Formation and Fibro-Inflammation in a Mutant Kras-Driven Pancreatic Cancer Model
Walcheck, M. T., Schwartz, P. B., Carrillo, N. D., Matkowskyj, K. A., Nukaya, M., Bradfield, C. A., & Ronnekleiv‐Kelly, S. M. (2024) · Pancreas · doi:10.1097/mpa.0000000000002357 · Cited by 5
Anakinra-Loaded Sphingomyelin Nanosystems Modulate In Vitro IL-1-Dependent Pro-Tumor Inflammation in Pancreatic Cancer
Abal-Sanisidro, M., Michele, D. L., Roma, S., Ceraolo, M. G., de la Fuente, M., Monte, L. B. D., & Protti, M. P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158085 · Cited by 5
Gut Microbiome: The Third Musketeer in the Cancer-Immune System Cross-Talk
Sharma, P., Jain, T., Sethi, V., Iyer, S., & Dudeja, V. (2020) · Journal of Pancreatology · doi:10.1097/jp9.0000000000000057 · Cited by 5
The role of γδ T17 cells in cardiovascular disease
Ling, S., You, Z., Li, Y., Zhang, J., Zhao, S., He, Y., & Chen, X. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr0822-761rr · Cited by 6
RAS: Circuitry and therapeutic targeting
Singh, G., Thakur, N., & Kumar, U. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110505 · Cited by 6
Immune cells in pancreatic cancer
Zhang, Y., McAllister, F. M., & di Magliano, M. P. (2014) · OncoImmunology · doi:10.4161/onci.29125 · Cited by 5
Self-citation
The IL-17A/IL-17RA Axis Is Not Related to Overall Survival and Cancer Stem Cell Modulation in Pancreatic Cancer
Li, J., Betzler, C., Lohneis, P., Popp, M. C., Qin, J., Kalinski, T., Wartmann, T., Bruns, C. J., Zhao, Y., & Popp, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062215 · Cited by 5
Clinical Implications of Mismatch Repair Deficiency in Pancreatic Ductal Adenocarcinoma
Kaplan, Z., Prezioso, E., Jain, A., Lavu, H., Yeo, C. J., Bowne, W. B., & Nevler, A. (2025) · Cancer Medicine · doi:10.1002/cam4.70960 · Cited by 4
Changes in intestinal microbiota in patients with pancreatic cancer: a systematic review and meta-analysis
Liang, M., Liu, Z., Zhang, R., Yang, J., Wang, X.-W., & Zhang, N. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1619323 · Cited by 4
Aging modulation of the immune system and immunotherapy efficacy in cancer
Wang, Y., Liang, M., Mao, Y., Zhu, W., Shen, X., & Guan, W. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1781885 · Cited by 5
RBPJ Deficiency Sensitizes Pancreatic Acinar Cells to KRAS-Mediated Pancreatic Intraepithelial Neoplasia Initiation
Pan, L., Mulaw, M. A., Gout, J., Guo, M., Zarrin, H., Schwarz, P., Baumann, B., Seufferlein, T. T. W., Wagner, M., & Oswald, F. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.07.013 · Cited by 4
Aryl Hydrocarbon Receptor Ligands Drive Pancreatic Cancer Initiation and Progression through Protumorigenic T-cell Polarization
Griffith, B. D., Kadiyala, P., McGue, J. J., Sun, L., Kumar, A., Espinoza, C. E., Donahue, K. L., Iyer, M. K., Speyer, C. B., Nelson, S., et al. (2025) · Cancer Discovery · doi:10.1158/2159-8290.cd-25-0377 · Cited by 5
Genetic alterations of interleukin-17 and related genes in human prostate cancer.
Lan, R., Zhang, K., Niu, T., & You, Z. (2019) · PubMed Central · Cited by 4
Inflammation and cancer
Mackenzie, G. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823397-9.00003-x · Cited by 4
Die ambivalente Rolle des Tumormikromilieus bei soliden Tumoren
Gaida, M. M. (2020) · Der Pathologe · doi:10.1007/s00292-020-00837-1 · Cited by 4
Injury and inflammation promote cancer progression at the anorectal junction
Petitpas, C., Mitoyan, L., Thevin, V., Martin, M., Hernández‐Vargas, H., Chevrier, V., Ollivier, A., Kaya, M., Poizat, F., Heinisch, M., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116552 · Cited by 3
Cytokine circuitry in pancreatic cancer: Targets for overcoming immune checkpoint inhibitor resistance in PDAC
Dhanisha, S. S., Salcedo-Noriega, M. F., Vaish, U., Kannan, A. B., Suryansh, S., Bhandari, S., Chatre, S., Jain, T., Dudeja, V., & Iyer, S. (2026) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2026.01.009 · Cited by 3
Oncogenic Kras targeting with MRTX1133 or Daraxonrasib specifically synergize with anti-CTLA4 to promote anti-tumor immunity in pancreatic cancer
Mahadevan, K. K., Maldonado, A. S., Li, B., Bickert, A. A., Perdyan, A., Kumbhar, S. V., Piya, S., Sockwell, A. M., Morse, S. J., Arian, K. A., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-75960-3 · Cited by 12
Self-citation
The prognostic role of γδ T cells in colorectal cancer based on nomogram
Ma, R., Gong, M., Sun, T., Su, L., & Li, K. (2023) · European journal of medical research · doi:10.1186/s40001-023-01452-5 · Cited by 3
Interleukin interrupted: A new strategy for the treatment of pancreatic cancer
Leach, S. D. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.2123insight1 · Cited by 3
Self-citation
Stories of drug repurposing for pancreatic cancer treatment—Past, present, and future
Ilmer, M., Weniger, M., Nieß, H., Wu, Y. F., Zhang, C., Westphalen, C. B., Krüger, S., Angele, M. K., Werner, J. M., D’Haese, J. G., et al. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819668-7.00009-9 · Cited by 3
Role of Lymphocytes in Cancer Immunity and Immune Evasion Mechanisms
Kushekhar, K., Chellappa, S., Aandahl, E. M., & Taskén, K. (2022) · Springer eBooks · doi:10.1007/978-3-030-98950-7_10 · Cited by 6
A new histopathological phenomenon: Pancreatic islet cell loss in the elderly population
Li, R., Yang, T., Zhang, M., Ren, K., Li, J., Sato, I., & Yi, S. (2023) · Digestive and Liver Disease · doi:10.1016/j.dld.2023.11.031 · Cited by 3
Impact of Recombinant Granulocyte Colony-Stimulating Factor During Neoadjuvant Therapy on Outcomes of Resected Pancreatic Cancer
Murthy, P., Zenati, M. S., AlMasri, S. S., DeSilva, A., Singhi, A. D., Paniccia, A., Lee, K. K. W., Simmons, R. L., Bahary, N., Lotze, M. T., et al. (2023) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2023.7070 · Cited by 5
Role of Inflammatory Cytokines in the Initiation and Progression of Pancreatic Cancer
Santharam, M. A., & Dhandapani, V. (2019) · Springer eBooks · doi:10.1007/978-981-32-9393-9_8 · Cited by 3
Identification of prognostic marker genes in head and neck squamous cell carcinoma: A study based on The Cancer Genome Atlas database and experimental validation
Zhong, Q., Zhou, L. Q., & Zhu, D. (2021) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.13186 · Cited by 3
Hiding in plain sight
Halbrook, C. J., & Crawford, H. C. (2019) · Science · doi:10.1126/science.aax9341 · Cited by 3
Antigen-presenting type-I conventional dendritic cells facilitate curative checkpoint blockade immunotherapy in pancreatic cancerPreprint
Mahadevan, K. K., Dyevoich, A. M., Chen, Y., Li, B., Sugimoto, H., Sockwell, A. M., McAndrews, K. M., Wang, H., Shalapour, S., Watowich, S. S., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.05.531191 · Cited by 3
Netrin G1 Ligand is a new stromal immunomodulator that promotes pancreatic cancerPreprint
Costa, D. B. V., Francescone, R., Franco‐Barraza, J., Luong, T., Graves, M., de Aquino, A. M., Steele, N. G., Gardiner, J. C., dos Santos, S. A. A., Ogier, C., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.15.594354 · Cited by 3
KRAS regulates IL-17 signal activity by affect the metastasis of osteosarcoma via an IL-17A-dependent manner
Bao, X., Zhang, N., Wang, C., Liu, S., Fan, A., Zheng, F., & Yang, C. (2025) · JBMR Plus · doi:10.1093/jbmrpl/ziaf056 · Cited by 2
The role of IL-17-related signaling in myelomagenesis, disease prognosis/progression, and therapeutic approach—a scoping review
Kulig, P., Rałowiec, A., Baumert, B., & Machaliński, B. (2025) · Clinical and Experimental Medicine · doi:10.1007/s10238-025-01728-6 · Cited by 2
The absence of IL17A favours cytotoxic cell function and improves antigen‐specific immunotherapies in pancreatic adenocarcinoma
Tiberi, G., Scagliotti, A., Curcio, C., Candiello, E., Villegas, P. A. D., Brugiapaglia, S., Mucciolo, G., Roux, C., Castellano, G., Curto, R., et al. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70442 · Cited by 2
LY6D identifies persistent stem-like cells driving pancreatic tumourigenesis
Shi, J., Wang, X., Tang, Y., Meng, S., Zhang, Z., Lu, P., Xu, J., Yu, F., Wang, X., Wang, Z., et al. (2026) · Gut · doi:10.1136/gutjnl-2025-336460 · Cited by 2
Aging Reshapes γ/δ T‐Cell Immunity Through a Type I Interferon–Foxo1 Axis
Durand, A., Porte, S., Xing, E., Wu, C., Bon, A. L., Auffray, C., Lucas, B., & Martin, B. (2026) · Aging Cell · doi:10.1111/acel.70389 · Cited by 2
Targeting KRAS and SHP2 signaling pathways for immunomodulation and improving treatment outcomes in solid tumors
Sahu, P., Mitra, A., & Ganguly, A. (2024) · International review of cytology · doi:10.1016/bs.ircmb.2024.01.005 · Cited by 2
Role of the Microbiome in Pancreatic Cancer
Kurtom, S., Sethi, V., & Dudeja, V. (2021) · Springer eBooks · doi:10.1007/978-3-030-53786-9_19 · Cited by 2
Targets and Strategies for Cancer Immunoprevention
Ünver, N., & Mohindroo, C. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2014-4_2 · Cited by 2
Immuno-Oncology in Pancreatic Cancer
Jamieson, N. B., & Steele, C. W. (2021) · Springer eBooks · doi:10.1007/978-3-030-53786-9_20 · Cited by 2
Acinar-to-ductal metaplasia in the pancreas requires a glycolytic switch and functional mitochondriaPreprint
Neuß, T., Wirges, N., Chen, M., Usluer, S., Oellinger, R., Lier, S., Dudek, M., Madl, T., Jastroch, M., Steiger, K., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.27.495427 · Cited by 2
KRAS and MYC synergistic inhibition: a powerful strategy targeting KRAS-mutant cancers
Yan, M., Liu, K., Xu, J., Liu, Y., Ji, L., & Zhang, S. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02659-w · Cited by 1
Human pancreatic progenitor organoids define genetic and epigenetic barriers to early PDAC transformation
Zhang, X., Wong, W., Cho, H. S., Yang, D., Dixon, G., Luo, R., Liu, D., Torre, D., Umeda, S., Gonzãlez, F., et al. (2026) · Developmental Cell · doi:10.1016/j.devcel.2026.04.012 · Cited by 2
Self-citation
Targeting Oncomucin-Driven Immunosuppression Improves the Efficacy of K-rasG12D Inhibition in Pancreatic Cancer
Bhyravbhatla, N., Alsafwani, Z. W., Thapa, I., Nallasamy, P., Atri, P., Segura, C. M. M., Park, M. A., Khan, I., Villalobos-Ayala, K., Marimuthu, S., et al. (2026) · Gastroenterology · doi:10.1053/j.gastro.2026.04.041 · Cited by 1
Targeting stroma-mediated T-cell exclusion and functional exhaustion in pancreatic ductal adenocarcinoma through CXCR4 and PD-1 blockade
Deipenbrock, A., Hofer, L., Wilmes, B. E., Cetin, T., Esposito, I., Weyhe, D., Stegmaier, J., & Teusch, N. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1844781 · Cited by 2
Stromal Inflammation in Pancreatic Cancer: Mechanisms and Translational Applications
Boyle, K. A., James, M. A., Tsai, S., Evans, D. B., & Dwinell, M. B. (2017) · Springer eBooks · doi:10.1007/978-1-4939-6631-8_55-1 · Cited by 1
The Trinity: Interplay among Cancer Cells, Fibroblasts, and Immune Cells in Pancreatic Cancer and Implication of CD8+ T Cell-Orientated Therapy
Hung, Y., Chen, L., & Hung, W. (2022) · Biomedicines · doi:10.3390/biomedicines10040926 · Cited by 1
Stromal Inflammation in Pancreatic Cancer: Mechanisms and Translational Applications
Boyle, K. A., James, M. A., Tsai, S., Evans, D. B., & Dwinell, M. B. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7193-0_55 · Cited by 1
You are the tumor queen, microbiome fiend, IL-17
Jana, J. A., & Overacre-Delgoffe, A. E. (2024) · Immunity · doi:10.1016/j.immuni.2023.12.011 · Cited by 1
The circulating inflammatory profile and tumour localisation in patients with pancreatic cancer
Kostro, P., Dorf, J., Kamocki, Z. K., Matowicka-Karna, J., Żendzian‐Piotrowska, M., & Maciejczyk, M. (2024) · Medical Studies · doi:10.5114/ms.2024.140979 · Cited by 1
Cancer Immunity and Immune Evasion Mechanisms
Chellappa, S., Aandahl, E. M., & Taskén, K. (2017) · Springer eBooks · doi:10.1007/978-3-319-39147-2_8 · Cited by 1
Obesity and cancer: the gammadelta T cell link
Bank, I. (2022) · Exploration of Immunology · doi:10.37349/ei.2022.00053 · Cited by 1
γδ T Cell Functions and Biology
Hayday, A., & Roberts, N. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.08010-3 · Cited by 1
The role of γδ T cells in pancreatic cancer: what could this mean for the clinic?
Daley, D., & Miller, G. (2017) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2017.1312344 · Cited by 1
Role of CD3+γδ-T cells in the association of obstructive sleep-disordered breathing and cancer
Staats, R., Rodrigues, R., Barros, A., Bacelar–Nicolau, L., Aguiar, M., Fernandes, D., Moreira, S., Simões, A. E. S., Silva‐Santos, B., Rodrigues, J. V., et al. (2019) · Sleep And Breathing · doi:10.1007/s11325-019-01842-2 · Cited by 1
nSMase2-mediated exosome secretion shapes the tumor microenvironment to immunologically support pancreatic cancerPreprint
Hendley, A. M., Ashe, S., Urano, A., Ng, M., Phu, T. A., Peng, X. L., Luan, C., Finger, A., Jang, G. H., Kerper, N. R., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.23.614610 · Cited by 1
Somatostatin Receptor Subtype 2 as Pancreatic Tumorigenesis Suppressor: Identification of a New Targetable Signaling Node
Crawford, H. C. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.025
Somatostatin Receptor Subtype 2 as Pancreatic Tumorigenesis Suppressor: Identification of a New Targetable Signaling Node
Grady, W. M. (2015)
Oncogenic KRAS and the Inflammatory Micro-Environment in Pancreatic Cancer
Chang, H.-H., Schmidt, A., & Eibl, G. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803505-4.00005-9
Pancreatic Cancer Fostered Immunosuppression Privileges Tumor Growth and
Gnatta, E., Plebani, M., & Basso, D. (2014)
Pancreatic Cancer Thrives on Hijacking a Homeostatic Tissue Repair Pathway
Pylayeva‐Gupta, Y. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.02.010
Molecular and morphologic study of pancreatic cancer evolution
Noë, M. (2020) · Utrecht University Repository (Utrecht University) · doi:10.33540/3
Vγ usage distinguishes pro- and anti-tumor intestinal γδ T cell subsetsPreprint
Reis, B. S., Darcy, P. W., Khan, I. Z., Eleso, O., Zhu, C., Schernthanner, M., Lockhart, A. A. K., Reed, A. C., Bortolatto, J., Castro, T. B. R., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.13.468487
Faculty Opinions recommendation of γδ T cells in cancer: a small population of lymphocytes with big implications.
Wiest, D. L., & Contreras, A. V. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.736794842.793573506
The Prospects of Immunotherapy in Pancreatic Cancer
Ying, H., & Yao, W. (2022) · Springer eBooks · doi:10.1007/978-3-031-05724-3_22
EFFECT OF REPETITIVE RFA ON THE IMMUNEVRESPONSE OF THE PATIENTS WITH INOPERABLE PANCREATIC CANCER
TORIA, N., Kikodze, N., Pantsulaia, I., Iobadze, M., Janikashvili, N., Mizandari, M., & Chikovani, T. (2023) · GEORGIAN SCIENTISTS · doi:10.52340/gs.2023.05.01.22
Role of γδ T Cells in Cancer Progression and Therapy
Padmaraju, V., Sankla, Y., & Malla, R. R. (2023) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2023050067
Immunotherapy in Pancreatic Cancer
Yeung, Z. P., & Kundranda, M. N. (2023) · Springer eBooks · doi:10.1007/978-3-031-38623-7_6
Identification of Potential Biomarkers associated with Prognosis and Pathogenesis of Pancreatic CancerPreprint
li, X., Wen, S., Zhao, Y., Tuerxun, H., & Zhao, Y. (2023) · Research Square · doi:10.21203/rs.3.rs-3709972/v1
DETERMINATION OF SERUM INTERLEUKIN-36 ALPHA, BETA, GAMMA AND INTERLEUKIN-17 LEVELS IN PATIENTS WITH MULTIPLE MYELOMA
Bilge, N. Y., Terzi, H., Doğan, H. O., Kablan, D., & Şencan, M. (2024) · Cumhuriyet Tıp Dergisi/Cumhuriyet Üniversitesi Tıp Fakültesi dergisi · doi:10.7197/cmj.1431762
IVT-mRNA reprogramming of myeloid cells for cancer immunotherapy
Jolly, K. J., & Zhang, F. (2024) · Advances in pharmacology · doi:10.1016/bs.apha.2024.04.004
Unveiling the Culprit: IL17 Signaling in the Pancreatic Epithelium Drives Tumorigenesis
Lee, K. E., & di Magliano, M. P. (2024) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-24-0479
Relationship of pancreatitis to pancreatic cancer: from population-based observations to preclinical and mechanistic insights
Zhang, X., Chen, Z., Zhao, X. H., Pan, J., Pandol, S. J., & Li, W. (2024) · Journal of Pancreatology · doi:10.1097/jp9.0000000000000188
Therapeutic Targeting of KRAS Oncogene in Pancreatic Ductal Adenocarcinoma (PDAC)
Song, J. J. (2024) · Journal of Student Research · doi:10.47611/jsrhs.v13i1.6375
Chronic inflammation induced immunosuppression
Greten, F. R., & Pesic, M. H. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-14064-8.00048-5
γδ T Cell Biology
Hayday, A., Vantourout, P., & Kabelitz, D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00286-6
FGF21 inhibits invasion and metastasis via IL-17A-Notch in pancreatic ductal adenocarcinoma
Li, F., Zheng, P., Li, X., Yang, Y., Zhou, H., & Li, L. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1680888
A Genetically Engineered Human Organoid Model Reveals Distinct Genetic and Epigenetic Barriers of Lineage Plasticity in Early PDAC TransformationPreprint
Zhang, X., Wong, W. D., Cho, H., Yang, D., Dixon, G., Luo, R., Liu, D., Torre, D., Umeda, S., Gonzãlez, F., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.09.710586
Self-citation
Seven subsets, two fates: mouse γδ T cells in cancer immunity
Mallu, A. C. T., Phinney, N. Z., Lupo, F., & Coffelt, S. B. (2026) · Trends in Immunology · doi:10.1016/j.it.2026.02.009
Study of HOXB8-mediated tumor suppression in a chicken embryo model : towards novel therapeutic targets for ERK-dependent cancers
Wilmerding, A. (2021) · doi:10.70675/d7d914aaz38f6z4bb4zba88z7b449192ae2f
Role of the early stage stroma-immune interactions in the tumor microenvironment of pancreatic adenocarcinoma
Wu, Z. (2021) · theses.fr (ABES) · doi:10.70675/e97fe804z820dz4c4bz843az1f81f0b86c85
MicroRNA-based strategies to overcome the immunotherapy barrier in pancreatic ductal adenocarcinoma
徐慧文, Wang, Q., Cao, R., Qiu, Z., Liu, Y., Hu, J., Zheng, G., & Cheng, C. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1744566
The interplay between p21-activated kinases and tumour-infiltrating dendritic cells and T cells and its implication in pancreatic cancer immunotherapy
Jian, R., Ma, Y., Nikfarjam, M., & He, H. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-02923-y
What Are the Practical Applications of Single-Cell Proteomics?
Orsburn, B. C. (2026) · Proteomes · doi:10.3390/proteomes14020026
GATA4 loss promotes mutant Kras -driven pancreatic ductal adenocarcinoma in the absence of canonical precursor lesionsPreprint
Madriles, F., de Andrés, M. P., Chesnokov, M., de Villarreal, J. M., Alonso‐Curbelo, D., del Pozo, N., Iglesias, M., Pau, E. C. D. S., Iovanna, J., Soriano, F., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.22.724502

Authors: McAllister, F., Bailey, J. M., Alsina, J., Nirschl, C. J., Sharma, R., Fan, H., Rattigan, Y., Roeser, J. C., Lankapalli, R. H., Zhang, H., Jaffee, E. M., Drake, C. G., Housseau, F., Maitra, A., Kolls, J. K., Sears, C. L., Pardoll, D. M., & Leach, S. D.
Affiliations: Johns Hopkins University (US)
Children's Hospital of Pittsburgh (US)
Corresponding author: Leach, Steven D.
ORCID: McAllister, Florencia
Bailey, Jennifer M.
Nirschl, Christopher J.
Sharma, Rajni
Fan, Hongni
Zhang, Hao
Jaffee, Elizabeth M.
Drake, Charles G.
Housseau, Franck
Maitra, Anirban
Kolls, Jay K.
Sears, Cynthia L.
Leach, Steven D.
Venue: Cancer Cell
Publisher: Elsevier BV
Published: 2014-05
Volume: 25
Issue: 5
Pages: 621-637
ISSN: 1535-6108 (ISSN-L)
DOI: 10.1016/j.ccr.2014.03.014
PMC: PMC4072043
OpenAlex: W2085605492
Cited by: 405
References: 63
Citations by year: 2026: 21 · 2025: 27 · 2024: 39 · 2023: 37 · 2022: 43 · 2021: 38 · 2020: 44 · 2019: 37 · 2018: 15 · 2017: 32 · 2016: 29 · 2015: 29 · 2014: 14
FWCI: 16.71
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 376 d)
Locations: Cancer Cell (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: Amgen
National Cancer Institute (P01CA134292, T32CA126607, F32CA157044)
National Institute of General Medical Sciences (T32GM066691)
National Institute of Allergy and Infectious Diseases (T32AI007247)
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK097087)
National Center for Research Resources (S10RR017933)
Topics: Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
Keywords: KRAS G12D, IL-17 signaling, pancreatic intraepithelial neoplasia, chronic pancreatitis, IL-17 receptor, pancreatic stroma, chronic inflammation, IL-17 inhibition
MeSH terms: Animals, Carcinoma in Situ, Cell Transformation, Neoplastic, Epithelial Cells, Hematopoietic System, Humans, Inflammation, Mice, Transgenic, Pancreas, Pancreatic Neoplasms, Signal Transduction, Proto-Oncogene Proteins p21(ras), Receptors, Antigen, T-Cell, gamma-delta, Chemoprevention, Interleukin-17, Mice, Receptors, Interleukin-17, Th17 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Oncogenic Kras Activates a Hematopoietic-to-Epithelial IL-17 Signaling Axis in Preinvasive Pancreatic Neoplasia

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks